Precipio Inc

-0.11 (-4.45%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)51.21M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.75 Million
Adjusted EPS-$0.10
See more estimates
10-Day MA$2.53
50-Day MA$2.92
200-Day MA$3.01
See more pivots

Precipio Inc Stock, NASDAQ:PRPO

4 Science Park, 3rd floor, New Haven, Connecticut 06511
United States of America
Phone: +1.203.787.7888
Number of Employees: 57


Precipio, a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.